Background: Hypothyroidism has been associated with impaired urinary concentrating ability. However, previous reports on thyroid hormone and urinary concentrating ability in humans only studied a limited number of patients with autoimmune thyroid disease or used healthy controls instead of paired analysis within the same patients. Objective: To study the urinary concentrating ability in athyreotic patients with differentiated thyroid cancer on and off levothyroxine treatment as they are exposed to different thyroid states as part of their treatment in the absence of an autoimmune disease. Design and Methods: We studied 9 patients (mean age of 42.7 years) during severe hypothyroid state (withdrawal of levothyroxine before radioactive iodine therapy) and TSH-suppressed state (on levothyroxine therapy). At these two points, serum and urine samples were collected after 14 h of overnight fasting without any food or drink. Results: Serum and urine osmolality were not significantly different between on and off levothyroxine treatment. Serum creatinine levels were significantly higher in patients off versus on levothyroxine treatment (87.0 vs. 71.0 µmol/L, respectively; p = 0.044) and, correspondingly, the estimated glomerular filtration rate was significantly lower (89.6 vs. 93.1 mL/min, respectively; p = 0.038). Conclusion: Short-term, severe hypothyroidism has no effect on urinary concentrating ability. Our study confirms the well-known effects of thyroid hormone on serum creatinine concentrations.

Keywords:
Hypothyroidism, Fluid deprivation, Urinary concentrating ability
1.
Roberts CG, Ladenson PW: Hypothyroidism. Lancet 2004; 363:793–803.
2.
Knepper MA, Kwon TH, Nielsen S: Molecular physiology of water balance. N Engl J Med 2015; 373:196.
3.
Chen YC, Cadnapaphornchai MA, Yang J, Summer SN, Falk S, Li C, Wang W, Schrier RW: Nonosmotic release of vasopressin and renal aquaporins in impaired urinary dilution in hypothyroidism. Am J Physiol Renal Physiol 2005; 289:F672–F678.
4.
Cadnapaphornchai MA, Kim YW, Gurevich AK, Summer SN, Falk S, Thurman JM, Schrier RW: Urinary concentrating defect in hypothyroid rats: role of sodium, potassium, 2-chloride co-transporter, and aquaporins. J Am Soc Nephrol 2003; 14:566–574.
5.
Discala VA, Kinney MJ: Effects of myxedema on the renal diluting and concentrating mechanism. Am J Med 1971; 50:325–335.
6.
Vaamonde CA, Michael UF, Oster JR, Sebastianelli MJ, Vaamonde LS, Klingler EL Jr, Papper S: Impaired renal concentrating ability in hypothyroid man. Nephron 1976; 17:382–395.
7.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC: The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160:526–534.
8.
Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501–509.
9.
Vargas F, Atucha NM, Sabio JM, Quesada T, Garcia-Estan J: Pressure-diuresis-natriuresis response in hyperthyroid and hypothyroid rats. Clin Sci (Lond) 1994; 87:323–328.
10.
Wang W, Li C, Summer SN, Falk S, Schrier RW: Polyuria of thyrotoxicosis: downregulation of aquaporin water channels and increased solute excretion. Kidney Int 2007; 72:1088–1094.
11.
Robertson GL, Shelton RL, Athar S: The osmoregulation of vasopressin. Kidney Int 1976; 10:25–37.
12.
Kreisman SH, Hennessey JV: Consistent reversible elevations of serum creatinine levels in severe hypothyroidism. Arch Intern Med 1999; 159:79–82.
13.
Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I: Changes in renal function in primary hypothyroidism. Am J Kidney Dis 1996; 27:195–198.
14.
El Ters M, Patel SM, Norby SM: Hypothyroidism and reversible kidney dysfunction: an essential relationship to recognize. Endocr Pract 2014; 20:490–499.
15.
Karanikas G, Schutz M, Szabo M, Becherer A, Wiesner K, Dudczak R, Kletter K: Isotopic renal function studies in severe hypothyroidism and after thyroid hormone replacement therapy. Am J Nephrol 2004; 24:41–45.
16.
Villabona C, Sahun M, Roca M, Mora J, Gomez N, Gomez JM, Puchal R, Soler J: Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci 1999; 318:277–280.
17.
Mariani LH, Berns JS: The renal manifestations of thyroid disease. J Am Soc Nephrol 2012; 23:22–26.
18.
Schlumberger M, Ricard M, De Pouvourville G, Pacini F: How the availability of recombinant human TSH has changed the management of patients who have thyroid cancer. Nat Clin Pract Endocrinol Metab 2007; 3:641–650.
19.
Li JH, He ZH, Bansal V, Hennessey JV: Low iodine diet in differentiated thyroid cancer: a review. Clin Endocrinol (Oxf) 2016; 84:3–12.
20.
Vannucci L, Parenti G, Simontacchi G, Rastrelli G, Giuliani C, Ognibene A, Peri A: Hypothyroidism and hyponatremia: data from a series of patients with iatrogenic acute hypothyroidism undergoing radioactive iodine therapy after total thyroidectomy for thyroid cancer. J Endocrinol Invest 2017; 40:49–54.
© 2017 European Thyroid Association
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.